Related Experiment Video
Updated: Dec 30, 2025
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
Fourth malignancy after treatment of Hodgkin's lymphoma: a case report
Wei Gui1, Liping Su1, Jingrong Wang1
1Department of Hematology, Shanxi Tumor Hospital Shanxi, China.
Objective:
To evaluate the incidence and treatment of the fourth malignancy in a Hodgkin's lymphoma (HL) patient.
Methods:
We reported a HL patient after treatment that developed the second, third, and fourth malignancies (chronic myeloid leukemia, chronic lymphocytic leukemia, and gastric adenocarcinoma) in relatively short time (75 months). The diagnosis was confirmed by pathology, bone marrow morphology, flow cytometry, karyotype and fusion gene examination.
Results:
He received surgery and chemotherapy. He achieved good response for triple malignancies. After diagnosis with gastric cancer, he orally administered compound tegafur capsule, apatinib and imatinib.
Conclusion:
The fourth malignancy of HL patient is extremely rare. We recommend a strict follow-up, for HL to detect multiple malignancies.
